Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Trilaciclib prior to chemotherapy in patients with metastatic triple-negative breast cancer: final efficacy and subgroup analysis from a randomized phase II studyClin. Cancer Res 2021 Dec 09;[EPub Ahead of Print], AR Tan, GS Wright, AR Thummala, MA Danso, L Popovic, TJ Pluard, HS Han, Ž Vojnović, N Vasev, L Ma, DA Richards, ST Wilks, D Milenković, J Xiao, J Sorrentino, J Horton, J O'Shaughnessy
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.